20-5302610-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_144773.4(PROKR2):āc.585G>Cā(p.Thr195=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.749 in 1,613,922 control chromosomes in the GnomAD database, including 453,028 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.73 ( 40975 hom., cov: 32)
Exomes š: 0.75 ( 412053 hom. )
Consequence
PROKR2
NM_144773.4 synonymous
NM_144773.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.51
Genes affected
PROKR2 (HGNC:15836): (prokineticin receptor 2) Prokineticins are secreted proteins that can promote angiogenesis and induce strong gastrointestinal smooth muscle contraction. The protein encoded by this gene is an integral membrane protein and G protein-coupled receptor for prokineticins. The encoded protein is similar in sequence to GPR73, another G protein-coupled receptor for prokineticins. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 20-5302610-C-G is Benign according to our data. Variant chr20-5302610-C-G is described in ClinVar as [Benign]. Clinvar id is 338858.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-5302610-C-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-2.51 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.75 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PROKR2 | NM_144773.4 | c.585G>C | p.Thr195= | synonymous_variant | 3/3 | ENST00000678254.1 | NP_658986.1 | |
PROKR2 | XM_017027646.2 | c.585G>C | p.Thr195= | synonymous_variant | 3/4 | XP_016883135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PROKR2 | ENST00000678254.1 | c.585G>C | p.Thr195= | synonymous_variant | 3/3 | NM_144773.4 | ENSP00000504128 | P1 | ||
PROKR2 | ENST00000217270.4 | c.585G>C | p.Thr195= | synonymous_variant | 3/3 | 1 | ENSP00000217270 | P1 | ||
PROKR2 | ENST00000678059.1 | c.477G>C | p.Thr159= | synonymous_variant | 3/3 | ENSP00000503366 |
Frequencies
GnomAD3 genomes AF: 0.734 AC: 111570AN: 152002Hom.: 40921 Cov.: 32
GnomAD3 genomes
AF:
AC:
111570
AN:
152002
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.746 AC: 187657AN: 251476Hom.: 70228 AF XY: 0.750 AC XY: 101993AN XY: 135918
GnomAD3 exomes
AF:
AC:
187657
AN:
251476
Hom.:
AF XY:
AC XY:
101993
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.750 AC: 1096444AN: 1461802Hom.: 412053 Cov.: 64 AF XY: 0.751 AC XY: 546485AN XY: 727220
GnomAD4 exome
AF:
AC:
1096444
AN:
1461802
Hom.:
Cov.:
64
AF XY:
AC XY:
546485
AN XY:
727220
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.734 AC: 111677AN: 152120Hom.: 40975 Cov.: 32 AF XY: 0.736 AC XY: 54701AN XY: 74362
GnomAD4 genome
AF:
AC:
111677
AN:
152120
Hom.:
Cov.:
32
AF XY:
AC XY:
54701
AN XY:
74362
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2427
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hypogonadotropic hypogonadism 3 with or without anosmia Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 27, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Oct 25, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at